Leana Marie Doherty, MD
Neurology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Doherty’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$37,044
Medicare paid this office $37,044 for 178 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,640 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $7,433 | $146 |
| Long return visit (40+ min) | 39 | $7,430 | $149 |
| New patient visit (60+ min) | 34 | $6,695 | $197 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,614 | $108 |
See all 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,640 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $7,433 | $146 |
| Long return visit (40+ min) | 39 | $7,430 | $149 |
| New patient visit (60+ min) | 34 | $6,695 | $197 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,614 | $108 |
| Return visit (30+ min) | 17 | $1,143 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,098 | $65 |
Who their Medicare patients are
178 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 18% · Women 57% · Also on Medicaid 21% · Health risk score 1.86. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Chronic kidney disease 42% · Diabetes 41% · Coronary heart disease 41% · Stroke 40% · Depression 33% · Heart failure 32% · Atrial fibrillation 27% · Dementia 20% · COPD 17% · Cancer 16%.
The office billed $147,535, Medicare allowed $48,189 and paid $37,044; for 305 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 178 | 305 | 74 | 1.86 | $147,535 | $37,044 |
| 2023 | 114 | 205 | 69 | 2.41 | $61,849 | $20,711 |
| 2022 | 137 | 292 | 70 | 2.00 | $72,004 | $24,514 |
| 2021 | 100 | 216 | 69 | 1.72 | $65,659 | $20,387 |
| 2020 | 151 | 588 | 67 | 2.01 | $178,065 | $47,285 |
| 2019 | 159 | 693 | 65 | 1.83 | $212,471 | $55,595 |
| 2018 | 81 | 339 | 70 | 1.66 | $73,980 | $18,741 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $6,422 | $90 |
| Long return visit (40+ min) | 28 | $4,959 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $3,905 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,818 | $96 |
2022: 8 services
| Long return visit (40+ min) | 33 | $5,467 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,733 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,093 | $77 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,203 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,893 | $100 |
| Return visit (30+ min) | 14 | $1,830 | $96 |
| New patient visit (60+ min) | 11 | $1,615 | $147 |
| Hospital discharge day management, more than 30 minutes | 11 | $898 | $82 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $6,726 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,848 | $158 |
| Long return visit (40+ min) | 12 | $1,649 | $127 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,256 | $90 |
| Return visit (30+ min) | 11 | $866 | $79 |
2020: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $25,975 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,542 | $177 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,356 | $91 |
| Long return visit (40+ min) | 26 | $2,188 | $81 |
| Microscopic genetic analysis of nerve tissue | 17 | $1,925 | $113 |
| Pathology examination of tissue using a microscope, intermediate complexity | 17 | $1,669 | $33 |
| New patient visit (60+ min) | 11 | $1,624 | $148 |
| Special stained specimen slides to examine tissue, initial procedure | 17 | $1,562 | $31 |
| Return visit (30+ min) | 14 | $1,313 | $69 |
2019: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $28,928 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,163 | $167 |
| Long return visit (40+ min) | 34 | $4,111 | $89 |
| New patient visit (60+ min) | 30 | $4,052 | $135 |
| Hospital discharge day management, more than 30 minutes | 31 | $2,942 | $92 |
| Microscopic genetic analysis of nerve tissue | 18 | $1,961 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,682 | $62 |
| Pathology examination of tissue using a microscope, intermediate complexity | 18 | $1,653 | $32 |
| Return visit (30+ min) | 27 | $1,643 | $59 |
| Special stained specimen slides to examine tissue, initial procedure | 18 | $1,552 | $30 |
2018: 5 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 35 | $5,859 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,898 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,739 | $171 |
| New patient visit (60+ min) | 15 | $2,144 | $143 |
| Hospital discharge day management, 30 minutes or less | 14 | $838 | $60 |
Drugs they prescribed that Part D paid
$339,044
Pharmacies billed $339,044 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (13 of 469) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
450 generic and 19 brand-name prescriptions · $339,044 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Radicava Ors | 12 | $175,344 | $14,612 |
| Pyridostigmine | 65 | $11,837 | $182 |
| Mycophenolate Mofetil | 28 | $8,461 | $302 |
| Gabapentin | 98 | $2,118 | $22 |
| Pregabalin | 28 | $1,179 | $42 |
See all 9 drugs
| Radicava Ors | 12 | $175,344 | $14,612 |
| Pyridostigmine | 65 | $11,837 | $182 |
| Mycophenolate Mofetil | 28 | $8,461 | $302 |
| Gabapentin | 98 | $2,118 | $22 |
| Pregabalin | 28 | $1,179 | $42 |
| Duloxetine | 40 | $780 | $19 |
| Prednisone | 90 | $603 | $7 |
| Lidocaine-Prilocaine | 19 | $315 | $17 |
| Tramadol | 13 | $40 | $3 |
Year by year
| 2024 | 469 | 92 | 3% (13) | 4% | $339,044 |
| 2023 | 613 | 96 | 2% (11) | 2% | $53,938 |
| 2022 | 381 | 78 | None | None | $26,851 |
| 2021 | 169 | 33 | 0% (0) | 11% | $326,482 |
| 2020 | 186 | 30 | None | 6% | $146,616 |
| 2019 | 110 | 26 | 0% (0) | None | $8,472 |
| 2018 | 49 | 15 | None | None | $37,420 |
| 2017 | 153 | 20 | 0% (0) | 29% | $108,396 |
| 2016 | 109 | 16 | 0% (0) | 40% | $126,356 |
| 2015 | 74 | 18 | 0% (0) | 45% | $94,695 |
| 2014 | 63 | 26 | None | 21% | $14,020 |
| 2013 | 73 | 33 | None | None | $3,489 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Pyridostigmine | 67 | $15,460 | $231 |
| Gabapentin | 154 | $3,329 | $22 |
| Azathioprine | 12 | $3,327 | $277 |
| Mycophenolate Mofetil | 27 | $2,858 | $106 |
| Pregabalin | 37 | $2,435 | $66 |
| Prednisone | 121 | $1,032 | $9 |
| Duloxetine | 37 | $982 | $27 |
| Lidocaine-Prilocaine | 22 | $379 | $17 |
| Tramadol | 11 | $28 | $3 |
2022: 7 drugs
| Mycophenolic Acid | 12 | $7,354 | $613 |
| Pyridostigmine | 31 | $3,299 | $106 |
| Gabapentin | 106 | $2,635 | $25 |
| Mycophenolate Mofetil | 18 | $1,800 | $100 |
| Pregabalin | 18 | $1,500 | $83 |
| Prednisone | 79 | $514 | $7 |
| Duloxetine | 15 | $386 | $26 |
2021: 5 drugs
| Gammaplex | Immune globulin | 13 | $307,696 | $23,669 |
| Mycophenolate Mofetil | None | 19 | $2,946 | $155 |
| Gabapentin | None | 23 | $325 | $14 |
| Prednisone | None | 32 | $138 | $4 |
| Omeprazole | None | 11 | $58 | $5 |
2020: 6 drugs
| Mycophenolate Mofetil | 24 | $19,076 | $795 |
| Pregabalin | 14 | $527 | $38 |
| Carbidopa-Levodopa | 13 | $499 | $38 |
| Duloxetine | 16 | $444 | $28 |
| Gabapentin | 22 | $348 | $16 |
| Prednisone | 32 | $131 | $4 |
2019: 3 drugs
| Duloxetine | 11 | $341 | $31 |
| Prednisone | 21 | $184 | $9 |
| Gabapentin | 12 | $157 | $13 |
2017: 7 drugs
| Copaxone | 12 | $72,067 | $6,006 |
| Ampyra | 11 | $26,285 | $2,390 |
| Tegretol | 13 | $2,658 | $204 |
| Valproic Acid | 13 | $709 | $55 |
| Divalproex | 12 | $425 | $35 |
| Levetiracetam | 20 | $165 | $8 |
| Duloxetine | 11 | $161 | $15 |
2016: 4 drugs
| Copaxone | 13 | $70,619 | $5,432 |
| Ampyra | 11 | $21,750 | $1,977 |
| Divalproex | 12 | $1,830 | $153 |
| Gabapentin | 16 | $92 | $6 |
2015: 4 drugs
| Copaxone | 11 | $67,775 | $6,161 |
| Divalproex | 12 | $1,825 | $152 |
| Atorvastatin | 12 | $222 | $19 |
| Gabapentin | 11 | $42 | $4 |
Money from drug and device companies
$120 in 2025
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | None | $120 | 1 payment
|
See the published payment
| Alexion Pharmaceuticals | Meals · 2025-10-29 | None | $120 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 77.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851634190
- Licence
- PA MD474035
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-04-05
- NPI last updated
- 2024-10-10
- NPI record certified
- 2024-10-10
This is when the NPI record was last certified, not a medical board exam.